G 392 (Montelukast sodium 10 mg (base))

Pill imprint G 392 has been identified as Montelukast sodium 10 mg (base).

Montelukast is used in the treatment of allergic rhinitis; asthma, maintenance; bronchospasm prophylaxis; asthma; copd and belongs to the drug class leukotriene modifiers. There is no proven risk in humans during pregnancy. Montelukast 10 mg (base) is not a controlled substance under the Controlled Substance Act (CSA).

Montelukast sodium

Imprint:

G 392

Strength:

10 mg (base)

Color:

Beige

Shape:

Round

Availability:

Prescription only

Drug Class:

Leukotriene modifiers

Pregnancy Category:

B - No proven risk in humans

CSA Schedule:

Not a controlled drug

Manufacturer:

Glenmark Generics Inc., USA

National Drug Code (NDC):

68462-0392

Inactive Ingredients:

microcrystalline cellulose
lactose monohydrate
croscarmellose sodium
hydroxypropyl cellulose
magnesium stearate
hypromellose 2910 (15000 mPa.s)
titanium dioxide
ferric oxide yellow
ferric oxide red
carnauba wax

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.